A. Oliva

Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force

R. Fielding, Y. Rolland, B. Vellas, 2022, The Journal of Frailty & Aging.

Intramyocardial cell-based therapy during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: The ELPIS phase I trial

D. Danford, J. Tweddell, L. Lambert, 2022, medRxiv.

The Design and Rationale of a Phase 2b, Randomized, Double-Blinded, and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Lomecel-B in Older Adults with Frailty

A. Newman, J. Walston, B. Hitchinson, 2022, The Journal of Frailty & Aging.

Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease

Tyler J. Wishard, G. Small, S. Bookheimer, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Safety and efficacy of Lomecel‐B in patients with mild Alzheimer’s disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial

Tyler J. Wishard, S. Bookheimer, Keyvan Yousefi, 2021, Alzheimer's & Dementia.

Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial

N. Hibino, D. Danford, S. Kutty, 2023, European heart journal open.

Challenges in developing Geroscience trials

L. Ferrucci, R. de Cabo, N. Barzilai, 2023, Nature communications.